Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0093 | 0.9 |